3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Interventions
Trastuzumab
16
pertuzumab
14
Capecitabine
14
Docetaxel
12
pyrotinib
11
Cyclophosphamide
11
Standard of Care
10
Paclitaxel
10
Letrozole
10
trastuzumab deruxtecan
9
Radiotherapy
9
Carboplatin
9
Fulvestrant
8
Drug Therapy
8
sacituzumab govitecan
7
dalpiciclib
7
exemestane
6
eribulin
6
Tamoxifen
6
Epirubicin
6
Anastrozole
6
pembrolizumab
5
palbociclib
5
abemaciclib
5
Surveys and Questionnaires
5
Neoadjuvant Therapy
5
Aromatase Inhibitors
5
camrelizumab
4
Sentinel Lymph Node Biopsy
4
Doxorubicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Breast Neoplasms
×
Antibodies, Bispecific
×
Clear all
NCT06404736
2024-05-08
QUEEN-Dream
Fudan University
Phase 2
Not yet recruiting
73 enrolled